Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
H A Wakelee, A Patnaik, B I Sikic, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 29, 2000
Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats
D S Han, F Li, L Holt, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 12, 1998
The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels
E Bajetta, L Ferrari, L Celio, et al.
Medical Physics
|
August 18, 2000
Radiochromic film dosimetry of a low energy proton beam
A Piermattei, R Miceli, L Azario, et al.
Physics in Medicine and Biology
|
October 26, 2000
Dosimetric characterization of silicon and diamond detectors in low-energy proton beams
S Onori, C De Angelis, P Fattibene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2013
Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution
D Mattavelli, R Miceli, S Radaelli, et al.
Endocrine-Related Cancer
|
May 30, 2008
Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines
L Cerquetti, B Bucci, R Marchese, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 17, 2001
The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers
A Martinetti, L Ferrari, L Celio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2006
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
U Veronesi, L Mariani, A Decensi, et al.
The Cancer Journal From Scientific American
|
April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy
G Gasparini, M Toi, R Miceli, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
H A Wakelee, A Patnaik, B I Sikic, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
October 29, 2000
Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats
D S Han, F Li, L Holt, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 12, 1998
The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels
E Bajetta, L Ferrari, L Celio, et al.
Medical Physics
|
August 18, 2000
Radiochromic film dosimetry of a low energy proton beam
A Piermattei, R Miceli, L Azario, et al.
Physics in Medicine and Biology
|
October 26, 2000
Dosimetric characterization of silicon and diamond detectors in low-energy proton beams
S Onori, C De Angelis, P Fattibene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2013
Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution
D Mattavelli, R Miceli, S Radaelli, et al.
Endocrine-Related Cancer
|
May 30, 2008
Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines
L Cerquetti, B Bucci, R Marchese, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 17, 2001
The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers
A Martinetti, L Ferrari, L Celio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2006
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
U Veronesi, L Mariani, A Decensi, et al.
The Cancer Journal From Scientific American
|
April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy
G Gasparini, M Toi, R Miceli, et al.
Page
of 10